Literature DB >> 2460040

Prenatal immune priming in malaria: antigen-specific blastogenesis of cord blood lymphocytes from neonates born in a setting of holoendemic malaria.

R S Desowitz1.   

Abstract

The Plasmodium falciparum-specific blastogenic response of cord blood lymphocytes (CBLs) from neonates born in an area of holoendemic malaria of Papua New Guinea was compared to that of CBLs from neonates born in Hawaii, where malaria transmission does not occur. The average blastogenesis stimulation index of the New Guinea CBLs was 4.5 times greater than that of the Hawaiian group of samples. Eight of the 24 New Guinea CBL samples had a stimulation index greater than ten and counts per minute ranging from 13,331-84,242, whereas all the Hawaiian CBL samples had a stimulation index less than four, and the highest count per minute was 2016. The data are interpreted as indicating that prenatal immune sensitization/priming to P. falciparum had occurred in some of the New Guinea neonates.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2460040     DOI: 10.1080/00034983.1988.11812218

Source DB:  PubMed          Journal:  Ann Trop Med Parasitol        ISSN: 0003-4983


  11 in total

1.  Placental malaria diminishes development of antibody responses to Plasmodium falciparum epitopes in infants residing in an area of western Kenya where P. falciparum is endemic.

Authors:  Phillip Cullison Bonner; Zhiyong Zhou; Lisa B Mirel; John G Ayisi; Ya Ping Shi; Anna M van Eijk; Juliana A Otieno; Bernard L Nahlen; Richard W Steketee; Venkatachalam Udhayakumar
Journal:  Clin Diagn Lab Immunol       Date:  2005-03

2.  Prenatal immune responses to Plasmodium falciparum erythrocyte membrane protein 1 DBL-alpha domain in Gabon.

Authors:  Cristina Tena-Tomás; Marielle K Bouyou-Akotet; Eric Kendjo; Maryvonne Kombila; Peter G Kremsner; Jürgen F J Kun
Journal:  Parasitol Res       Date:  2007-05-29       Impact factor: 2.289

3.  Distinct Th1- and Th2-Type prenatal cytokine responses to Plasmodium falciparum erythrocyte invasion ligands.

Authors:  Indu Malhotra; Peter Mungai; Eric Muchiri; John Ouma; Shobhona Sharma; James W Kazura; Christopher L King
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

4.  Congenital exposure to Plasmodium falciparum antigens: prevalence and antigenic specificity of in utero-produced antimalarial immunoglobulin M antibodies.

Authors:  Guoling Xi; Rose G F Leke; Lucy W Thuita; Ainong Zhou; Robert J I Leke; Robinson Mbu; Diane Wallace Taylor
Journal:  Infect Immun       Date:  2003-03       Impact factor: 3.441

5.  Newborn splenic volumes vary under different malaria endemic conditions.

Authors:  J A Corkill; B J Brabin; D F MacGregor; M P Alpers; R D Milner
Journal:  Arch Dis Child       Date:  1989-04       Impact factor: 3.791

6.  Plasmodium falciparum infection of the placenta affects newborn immune responses.

Authors:  J Ismaili; M van der Sande; M J Holland; I Sambou; S Keita; C Allsopp; M O Ota; K P W J McAdam; M Pinder
Journal:  Clin Exp Immunol       Date:  2003-09       Impact factor: 4.330

7.  Plasmodium falciparum-specific immunoglobulin G (IgG), IgM, and IgE antibodies in paired maternal-cord sera from east Sepik Province, Papua New Guinea.

Authors:  R S Desowitz; J Elm; M P Alpers
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.441

Review 8.  Congenital Plasmodium falciparum malaria in sub-Saharan Africa: a rarity or frequent occurrence?

Authors:  C J Uneke
Journal:  Parasitol Res       Date:  2007-06-05       Impact factor: 2.289

9.  Can prenatal malaria exposure produce an immune tolerant phenotype? A prospective birth cohort study in Kenya.

Authors:  Indu Malhotra; Arlene Dent; Peter Mungai; Alex Wamachi; John H Ouma; David L Narum; Eric Muchiri; Daniel J Tisch; Christopher L King
Journal:  PLoS Med       Date:  2009-07-28       Impact factor: 11.069

10.  Three different Plasmodium species show similar patterns of clinical tolerance of malaria infection.

Authors:  Ivo Müller; Blaise Genton; Lawrence Rare; Benson Kiniboro; Will Kastens; Peter Zimmerman; James Kazura; Michael Alpers; Thomas A Smith
Journal:  Malar J       Date:  2009-07-14       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.